Journal profile · PHARMACOLOGY & PHARMACY

Pharmacia

ISSN 0428-0296 · eISSN 2603-557X · Pensoft Publishers · Bulgaria

Pharmacia: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.5 (journal website); fully open access; APC charged, amount not published; review about 12 weeks (community reports); 259 articles in 2025; indexed in ESCI and Scopus.

Impact factor1.5From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 12 weeksCommunity average
APCCharged, amount not publishedFully open access
Acceptance—No reports yet
Articles per year2592025 · OpenAlex count

Scope

Aims, scope and focus

Pharmacia is published by Pensoft Publishers and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Computational Drug Discovery Methods and Essential Oils and Antimicrobial Activity, together about 21% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

The journal Pharmacia publishes original research papers, preliminary communications, short communications (notes) and review articles, in the pharmaceutical and related sciences.The Journal also publishes announcements, reports of conferences, biographies (anniversaries, awards, etc.) as well as book reviews.Pharmacia is a multidisciplinary journal devoted to pharmaceutical and allied sciences. Topics covered are: analytics, biochemistry, biopharmaceutics, biotechnology, cell cultures, clinical pharmacy, drug delivery, drug design, drug disposition, drug stability, medicinal chemistry, metabolism, molecular modeling, basic and clinical pharmacology, pharmacognosy, pharmacoepidemiology, pharmacoeconomics, pharmacodynamics and pharmacokinetics, social pharmacy, radiopharmaceuticals, toxicology.The journal is published by the Bulgarian Pharmaceutical Science Society since 1954. Since 2019, it is published in a collaboration with the ARPHA platform of Pensoft Publishers. The journal archive is available online since 2007.

From the journal's Aims & Scope

Research area (LetPub): PHARMACOLOGY & PHARMACY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Pharmaceutical Practices and Patient OutcomesMedicine8%
  2. Computational Drug Discovery MethodsComputer Science6.9%
  3. Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.1%
  4. Synthesis and biological activityChemistry6.1%
  5. Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences5.7%
  6. Phytochemicals and Antioxidant ActivitiesMedicine5.3%
  7. Natural Antidiabetic Agents StudiesMedicine4.5%
  8. Medication Adherence and ComplianceMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPharmacology & PharmacyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPharmacology & PharmacyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
1.5Publisher website ·
CiteScore 2026-06
2.5LetPub ·
CiteScore (publisher)
2.5Publisher website ·
SJR 2026-06
0.33LetPub ·
SNIP 2026-06
0.57LetPub ·
SNIP (publisher)
0.57Publisher website ·
h-index
24OpenAlex ·
i10-index
146OpenAlex ·
2-year mean citedness
1.73OpenAlex ·
Self-citation rate
6.7%LetPub ·
Share of gold OA articles
98.42%LetPub ·

Volume

Articles per year
262LetPub ·

Articles by year OpenAlex count · 1,293 in total · the current year is incomplete

YearArticlesOpen accessCitations
202626426442
2025259259404
2024248248888
2023175175888
2022129129852
20211201201,040

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 12 weeksLetPub ·
Submission to publication (journal-reported)
about 12 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 800YesCC BY
OpenAlexEUR 100——
LetPubEUR 800Yes—
Publisher websiteEUR 500 / EUR 1,000——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review
AI use Use of AI

Authors must be transparent about the use of Artificial Intelligence tools such as ChatGPT and other large language models in the manuscript preparation, and disclose details of how the AI tool was used within the "Materials and Methods" section.

Source ↗Publisher website ·
Authorship Authorship/Contributorship

Some journals are integrated with Contributor Role Taxonomy (CRediT), in order to recognise individual author input within a publication, thereby ensuring professional and ethical conduct, while avoiding authorship disputes, gift / ghost authorship and similar pressing issues in academic publishing. During manuscript submission, the submitting author is strongly recommended to specify a contributo…

Source ↗Publisher website ·
Conflicts of interest Conflict of interest

During the editorial process, the following relationships between editors and authors are considered conflicts of interest: Colleagues currently working in the same research group or department, recent co-authors, and doctoral students for which the editor served as committee chair. During the submission process, the authors are kindly advised to identify possible conflicts of interest with the jo…

Source ↗Publisher website ·
Publication ethics Publication Ethics and Malpractice Statement

GeneralThe publishing ethics and malpractice policies follow the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA), the NISO Recommended Practices for the Presentation and Identification of E-Journals (PIE-J), and, where relevant, the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical…

Source ↗Publisher website ·
License & copyright License and Copyright Agreement

In submitting the manuscript to any of Pensoft’s journals, authors certify that: They are authorized by their co-authors to enter into these arrangements. The work described has not been published before (except in the form of an abstract or as part of a published lecture, review or thesis); it is not under consideration for publication elsewhere; its publication has been approved by all author(s)…

Source ↗Publisher website ·
Open access Open Access

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Source ↗Publisher website ·
Peer review Peer Review

This journal uses a double-blind peer review process, which means that both reviewer and author's names are concealed throughout the review process. To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not reveal their identity. Please consider the Editor and Reviewer Guidelines in the About webpage of this journal for more details and stepwise instruct…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Pensoft Publishers
Country or region
Bulgaria
Language
English
ISSN
0428-0296
Electronic ISSN
2603-557X
Official links

FAQ

Frequently asked questions about Pharmacia

What CAS zone is Pharmacia in?

In the 2025 upgraded edition of the CAS Journal Ranking, Pharmacia is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Pharmacia?

The journal's website gives an impact factor of 1.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.5, h-index 24.

How long does peer review take at Pharmacia?

Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Pharmacia?

According to LetPub and DOAJ records, Pharmacia is indexed in ESCI, Scopus and DOAJ.

Is Pharmacia open access, and what is the APC?

Pharmacia is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .